WCP’s Life Sciences practice combines a unique blend of senior investment banking, operating, and scientific expertise to maximize the value of our client’s medical assets. Whether we are working on a strategic partnership, capital raise, or merger & acquisition transaction, our sole objective is to see your many years of prior innovation and hard work come to fruition.

Our team is expert in navigating the minefields of development stage asset valuation, regulatory and CMS pathways, intellectual property assessment, manufacturing, and competitive ecosystem analysis to position your products and/or services to achieve their maximum potential.

Our team is visible in the industry because we speak at a wide range of medical conferences around the world. We find that our global reach matches up well with our clients’ needs and the global nature of our business.

Our Life Sciences group covers a broad range of disciplines within the Life Sciences industry, namely in Therapeutics, Devices, Diagnostics, and Services. We thrive on tough challenges and are passionate about seeing great therapies, technologies, and services improve the lives of people around the globe.